New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
( MENAFN - Mid-East Info) DUBAI, United Arab Emirates; January 2025 - Mayo clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.